Embr Labs, makers of Embr Wave, a wearable to treat the symptoms of menopause, raised $35 million via intellectual property-based debt financing. Led by GT Investment Partners (Ghost Tree Partners) in collaboration with Aon, the financing will fuel Embr’s consumer growth strategy via retail and geographic expansion.
“Women today are seeking natural, non-hormonal alternatives to control their symptoms of menopause, and the Embr Wave is the solution they’ve been looking for,” Elizabeth Gazda, CEO of Embr Labs, said. “Through our partnership with Ghost Tree, Embr Labs is able to accelerate the fulfillment of our mission to provide this groundbreaking technology to women everywhere.”
The influx of new capital will support Embr’s growth and continued expansion into new retail channels and markets.
“We recognized Embr’s market leadership and the company’s rapid growth potential,” David Byrne, managing director at Ghost Tree Partners, said. “We are pleased to support the company as the investment community has yet to recognize the massive unmet need the menopause segment presents. We’re excited to provide the capital to support the company’s retail growth and geographical expansion.”
“Innovation drives growth, and intellectual property can be the valuable asset created from that innovation,” Lewis Lee, CEO of IP solutions at Aon, said. “We are excited to support innovative companies with intellectual property portfolios like Embr Labs to help them unlock the potential value of those IP assets and pursue growth independent of equity market volatility.”
